OMIA:002231-9796 : Melanoma, generic in Equus caballus (horse)

In other species: domestic cat

Categories: Neoplasm

Mendelian trait/disorder: unknown

Mode of inheritance: Somatic mutation

Disease-related: yes

Species-specific description: see also OMIA:001356-9796 : Coat colour, grey/gray in Equus caballus as gray horses have an increased risk of developing melanomas

Molecular basis: Wong et al. (2019) performed "a cross-species analysis by sequencing tumor-germline pairs from 46 primary human muscosal, 65 primary canine oral and 28 primary equine melanoma cases from mucosal sites. ... As the gray phenotype, associated with progressive silvering of colored hair, has been linked to melanoma development in horses, we obtained a coat color phenotype for each case from clinical records ... . In the cutaneous melanomas, samples with a higher mutational load were generally from horses without the gray coat phenotype, suggesting a different path to melanoma development in these cases ... . Although the gray phenotype is known to predispose to melanomas in and around mucosal sites, a definitive association between this coat color phenotype and mutational load was not evident for mucocutaneous/mucosal-like cases." The authors identified somatic mutations in several driver genes: " The most prominent driver genes were NRAS ... and TP53 ... , while two cases had mutations in BRAF. Mutations were also observed in PTEN ... , KIT ... , and RB1 ... , with 14% of samples carrying a mutation in at least one of these genes ... . Intriguingly, we also found C>T missense mutations in the KNSTRN gene ... , in 1 cutaneous melanoma ... and two mucosal-like samples with a high mutation rate and UV signature ... . ... As noted above, as a comparator to our sequencing of equine melanomas from in and around mucosal sites, we sequenced 32 cases of equine cutaneous melanoma ... . With the exception of one NRAS Q61R mutation, these tumors lacked point or indel mutations in known melanoma driver genes ... , suggesting a distinct clinical entity or an alternative path to melanoma development." The authors also investigated DNA copy number profiles in equine melanomas: "frequent gain of chromosome 25 and loss of chromosome 31 was observed in tumors from mucosal-like or mucocutaneous sites." Druml et al. (2022): "Several studies have documented a genetic melanoma predisposition which is referred to the 4.6 kb duplication in intron 6 of STX17 and its surrounding haplotype. However, the genetic background and mechanisms responsible for differences in etiopathogenesis of equine dermal melanomatosis still remain unknown. In the current study, we performed a genome wide association analysis in 141 Lipizzan horses and subsequently identified one candidate gene on chromosome 24 putatively involved in melanoma pathogenesis in gray horses. The associated SNP was located in the intronic region of DPF3, a gene which is involved in humans in cell growth, proliferation, apoptosis and motility of cancer cells. The replication study in 1210 horses from seven breeds demonstrated, that the G/G genotype of the DPF3 associated SNP exhibits putative melanoma suppression effects."

Cite this entry

Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2024). OMIA:002231-9796: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70

References

Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.

2024 Andersson, L. :
White horses - non-coding sequences drive premature hair greying and predisposition to melanoma. Ups J Med Sci 129, 2024. Pubmed reference: 38571883. DOI: 10.48101/ujms.v129.10626.
Brodesser, D.M., Kummer, S., Eichberger, J.A., Schlangen, K., Corteggio, A., Borzacchiello, G., Bertram, C.A., Brandt, S., Pratscher, B. :
Deregulation of metalloproteinase expression in gray horse melanoma ex vivo and in vitro. Cells 13:956, 2024. Pubmed reference: 38891088. DOI: 10.3390/cells13110956.
Bulnes, F., Argüelles, D., Buzón, A., García-Álamo, K., Rodríguez-Gómez, I.M., Hernández, E., Mozos, E. :
Concomitant melanoma and keratoma affecting the equine digit: clinical, pathological, and long-term follow-up findings. BMC Vet Res 20:444, 2024. Pubmed reference: 39354566. DOI: 10.1186/s12917-024-04269-4.
Durward-Akhurst, S.A., Marlowe, J.L., Schaefer, R.J., Springer, K., Grantham, B., Carey, W.K., Bellone, R.R., Mickelson, J.R., McCue, M.E. :
Predicted genetic burden and frequency of phenotype-associated variants in the horse. Sci Rep 14:8396, 2024. Pubmed reference: 38600096. DOI: 10.1038/s41598-024-57872-8.
Hollis, A.R. :
Equine Melanoma Updates. Vet Clin North Am Equine Pract 40:431-439, 2024. Pubmed reference: 39266414. DOI: 10.1016/j.cveq.2024.07.008.
Labelle, A.L., Gemensky Metzler, A.M., McMullen, R.J., Wiggans, K.T., Labelle, P., Hamor, R.E. :
Equine intraocular melanocytic neoplasia. Can Vet J 65:1048-1054, 2024. Pubmed reference: 39355695.
Rubin, C.J., Hodge, M., Naboulsi, R., Beckman, M., Bellone, R.R., Kallenberg, A., J'Usrey, S., Ohmura, H., Seki, K., Furukawa, R., Ohnuma, A., Davis, B.W., Tozaki, T., Lindgren, G., Andersson, L. :
An intronic copy number variation in Syntaxin 17 determines speed of greying and melanoma incidence in Grey horses. Nat Commun 15:7510, 2024. Pubmed reference: 39209879. DOI: 10.1038/s41467-024-51898-2.
2023 Haughan, J., Ortved, K.F., Robinson, M.A. :
Administration and detection of gene therapy in horses: A systematic review. Drug Test Anal 15:143-162, 2023. Pubmed reference: 36269665. DOI: 10.1002/dta.3394.
2022 Druml, T., Brem, G., Horna, M., Ricard, A., Grilz-Seger, G. :
DPF3, a putative candidate gene for melanoma etiopathogenesis in gray horses. J Equine Vet Sci 108:103797, 2022. Pubmed reference: 34801788. DOI: 10.1016/j.jevs.2021.103797.
Yi, Z., Gao, Y., Yu, F., Zhu, Y., Liu, H., Li, J., Murua Escobar, H. :
Interventions for treatment of cutaneous melanoma in horses: a structured literature review. Vet Res Commun 47:347-360, 2022. Pubmed reference: 36329228. DOI: 10.1007/s11259-022-10023-8.
2019 Sánchez-Guerrero, M.J., Solé, M., Azor, P.J., Sölkner, J., Valera, M. :
Genetic and environmental risk factors for vitiligo and melanoma in Pura Raza Español horses. Equine Vet J 51:606-611, 2019. Pubmed reference: 30624804. DOI: 10.1111/evj.13067.
Wong, K., van der Weyden, L., Schott, C.R., Foote, A., Constantino-Casas, F., Smith, S., Dobson, J.M., Murchison, E.P., Wu, H., Yeh, I., Fullen, D.R., Joseph, N., Bastian, B.C., Patel, R.M., Martincorena, I., Robles-Espinoza, C.D., Iyer, V., Kuijjer, M.L., Arends, M.J., Brenn, T., Harms, P.W., Wood, G.A., Adams, D.J. :
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nat Commun 10:353, 2019. Pubmed reference: 30664638. DOI: 10.1038/s41467-018-08081-1.
2013 Metcalfe, L.V., O'Brien, P.J., Papakonstantinou, S., Cahalan, S.D., McAllister, H., Duggan, V.E. :
Malignant melanoma in a grey horse: case presentation and review of equine melanoma treatment options. Ir Vet J 66:22, 2013. Pubmed reference: 24196087. DOI: 10.1186/2046-0481-66-22.
Moore, J.S., Shaw, C., Shaw, E., Buechner-Maxwell, V., Scarratt, W.K., Crisman, M., Furr, M., Robertson, J. :
Melanoma in horses: Current perspectives. Equine Veterinary Education 25:144-151, 2013. DOI: doi.org/10.1111/j.2042-3292.2011.00368.x.

Edit History


  • Created by Frank Nicholas on 28 Jan 2020
  • Changed by Imke Tammen2 on 15 Feb 2023
  • Changed by Imke Tammen2 on 18 Apr 2023
  • Changed by Imke Tammen2 on 02 Sep 2024